Announcements
Announcement of the expiration of the Company’s 2022 cash capital increase call period and the issuance of stocks
1.Date of occurrence of the event:2022/04/18 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:The Company’s 2022 …
AEMPS of Spain revokes previous approval for the Active Cancer Immunotherapy, OBI-822, to proceed to Phase III Clinical Trial
1.Date of occurrence of the event:2022/04/06 2.New drug name or code:Active Cancer Immunotherapy OBI-822 (Adagloxad Simolenin) 3.Indication:OBI-822 is a therapeutic cancer vaccine classified as active cancer immunotherapy. Globo H-KLH conjugate …
Announcement of the Company’s full receipt of cash capital increase in 2022 and the reference date of capital increase
1.Date of occurrence of the event: 2022/03/25 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): Head office 4.Reciprocal shareholding ratios: None 5.Cause of …
Announcement of not Distributing Dividends in 2021
1.Date of the board of directors resolution:2022/03/18 2.Year or quarter which dividends belong to :2021 3.Period which dividends belong to:2021/1/1 to 2021/12/31 4.Appropriations of earnings in cash dividends to shareholders …
The Company’s Board of Directors resolved to convene the 2022 Annual General Shareholders’ Meeting
1.Date of the board of directors resolution:2022/03/18 2.General shareholders’ meeting date:2022/06/27 3.General shareholders’ meeting location:Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Da’ an Dist., …
Announcement of 2021 Consolidated Financial Statements were approved by the Board of Directors
1.Date of the board of directors submitted or approved:2022/03/18 2.Date of the audit committee approved:2022/03/18 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2021/01/01~2021/12/31 …
Supplemental announcement-subscription rights to the cash issue forfeited by directors of the Company reaching 50% and made to specific persons
1.Date of occurrence of the event: 2022/03/17 2.Reason for the forfeiture of subscription rights by the directors nd supervisors: Group investment strategy, shares forfeited are made to other investment company. …
Subscription rights to the cash issue forfeited by directors of the Company reaching 50% and subscription being made available to specific persons
1.Date of occurrence of the event:2022/03/17 2.Reason for the forfeiture of subscription rights by the directors nd supervisors:Overall investment strategy and financial planning considerations. 3.Name of director/supervisor, number of shares …
Announcement of calls on unpaid shares of 2022 cash capital increase
1.Date of occurrence of the event:2022/03/17 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:The payment period …
TFDA has granted the approval for the active cancer immunotherapy OBI-833 to proceed to a Phase II clinical trial
1.Date of occurrence of the event: 2022/02/23 2.New drug name or code: Active cancer immunotherapy, OBI-833 3.Indication: OBI-833 is a therapeutic cancer vaccine against Globo H, which is classified as …